| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $58K | +20.8% | +2800.0% |
| R&D Expense | $1.1M | -5.9% | -2.8% |
| SG&A Expense | $3.1M | +10.2% | -4.8% |
| Operating Income | -$4.6M | -17.7% | -5.9% |
| Pre-tax Income | -$4.3M | -20.1% | -13.3% |
| Income Tax | $0 | — | — |
| Net Income | -$4.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.1M | -0.9% | -31.8% |
| Accounts Receivable | $19K | -60.4% | — |
| Current Assets | $28.4M | -9.8% | -35.4% |
| Total Assets | $38.0M | -9.2% | -31.7% |
| Current Liabilities | $2.1M | +6.8% | -71.0% |
| Total Liabilities | $8.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.8M | — | — |
| Capital Expenditures | $17K | — | — |
| Investing Cash Flow | $3.7M | — | — |
| Financing Cash Flow | -$19K | — | — |
| Free Cash Flow | -$9.9M | — | — |
| -13.3% |
| EPS (Basic) | -$1.18 | -19.2% | -10.3% |
| EPS (Diluted) | -$1.18 | -19.2% | -10.3% |
| +0.5% |
| -13.9% |
| Stockholders' Equity | $29.3M | -11.7% | -35.6% |